Thonglor : (+66) 61-171-1000

Silom : (+66) 61-172-8594

Protecting Your Heart Health

Table of Contents

How HIV Damages the Body

Many people think about weight management mainly in terms of appearance, clothing size, or body shape. However, weight is also closely connected with the health of the heart and blood vessels.

Excess body weight can affect blood pressure, cholesterol levels, blood sugar control, inflammation, and the amount of fat stored around internal organs. Over time, these changes may increase cardiovascular risk.

This is why modern weight management is not only about losing kilograms. It is about improving overall health, reducing risk factors, and supporting long-term wellbeing.

Research has shown that obesity and cardiovascular disease are closely linked. The SELECT trial investigated whether medical weight management with semaglutide could reduce cardiovascular events in adults with overweight or obesity and established cardiovascular disease but without diabetes. fileciteturn3file0

Understanding the relationship between weight and heart health can help patients make informed decisions about prevention, lifestyle changes, and medical support.

What Is the Connection Between Weight Management and Heart Health?

Weight management and heart health are connected because excess body fat can influence several systems throughout the body.

When the body carries excess fat, especially visceral fat around the organs, it may contribute to:

  • Increased inflammation

  • Insulin resistance

  • Higher blood pressure

  • Abnormal cholesterol levels

  • Increased strain on the heart

  • Higher risk of cardiovascular disease

However, weight is only one part of the picture. Two people with the same BMI can have very different levels of health risk depending on body composition, lifestyle, genetics, and existing medical conditions.

This is why a complete health assessment is often more useful than looking at weight alone.

Why Obesity Can Increase Cardiovascular Risk

Obesity is considered a chronic health condition because it can affect many organs and systems.

The heart may be affected through several pathways:

Higher Blood Pressure

Extra body weight can increase the workload on the heart and contribute to higher blood pressure.

Blood Sugar Changes

Excess weight can increase the risk of insulin resistance and prediabetes, which may progress to type 2 diabetes in some individuals.

Cholesterol Changes

Obesity may be associated with unhealthy cholesterol patterns, including higher LDL cholesterol and triglycerides.

Inflammation

Fat tissue is not only a storage area for energy. It can release inflammatory signals that may affect blood vessels and cardiovascular health.

Managing weight can help address several of these risk factors together.

Weight Management Is More Than Losing Weight

A common misconception is that successful weight management is only about reaching a certain number on the scale.

In reality, healthy weight management focuses on improving multiple areas, including:

  • Maintaining muscle mass

  • Improving eating habits

  • Increasing physical activity

  • Supporting blood sugar control

  • Improving blood pressure

  • Building sustainable routines

Even moderate weight changes can have meaningful effects on some health markers.

A doctor may focus on improving overall metabolic health rather than chasing a specific appearance goal.

What Did the SELECT Trial Show?

The SELECT trial was a large international clinical study that examined whether semaglutide could reduce cardiovascular risk in adults with overweight or obesity.

The study included:

  • 17,604 participants

  • Adults aged 45 years or older

  • BMI of 27 or higher

  • Existing cardiovascular disease

  • No history of diabetes

Participants received either weekly semaglutide 2.4 mg or placebo and were followed for an average of approximately 39.8 months. fileciteturn3file0

The main cardiovascular outcome measured was a combination of:

  • Death from cardiovascular causes

  • Non-fatal heart attack

  • Non-fatal stroke

How Did Weight Management Affect Cardiovascular Outcomes?

In the SELECT trial:

  • 6.5% of participants receiving semaglutide experienced a major cardiovascular event

  • 8.0% of participants receiving placebo experienced a major cardiovascular event

The reported hazard ratio was 0.80, meaning there was a relative reduction in the risk of the primary cardiovascular outcome in the semaglutide group compared with placebo in this specific study population. fileciteturn3file0

These findings are important because they suggest that treating obesity may have benefits beyond weight reduction for certain patients at higher cardiovascular risk.

However, the results should not be applied to every person with excess weight. Treatment suitability depends on individual health factors.

How Weight Management May Improve Heart Health

Weight management may support cardiovascular health through several changes.

Improving Waist Circumference

Abdominal fat is an important marker of metabolic risk.

The SELECT trial reported greater reductions in waist circumference among participants receiving semaglutide compared with placebo. fileciteturn3file0

Supporting Blood Pressure Control

Blood pressure is one of the most important cardiovascular risk factors.

The study reported reductions in both systolic and diastolic blood pressure with semaglutide compared with placebo. fileciteturn3file0

Supporting Metabolic Markers

The trial also observed improvements in markers including:

  • HbA1c

  • Lipid levels

  • C-reactive protein

These findings highlight why weight management should include monitoring of overall health, not only body weight.

Who May Benefit From a Heart Health and Weight Assessment?

A medical assessment may be useful for people who have:

  • BMI above recommended ranges

  • Family history of heart disease

  • High blood pressure

  • High cholesterol

  • Prediabetes

  • Difficulty losing weight despite lifestyle changes

  • Fatty liver concerns

  • PCOS-related metabolic concerns

  • Previous cardiovascular disease

Not everyone needs medication. Some people may benefit from nutrition support, exercise planning, lifestyle changes, or monitoring of health markers.

When Should You Consider Medical Weight Management?

You may consider speaking with a healthcare professional if:

  • Weight is affecting your health

  • You have tried lifestyle changes without lasting results

  • Your appetite feels difficult to manage

  • You have metabolic concerns

  • You have weight-related conditions

  • You want to understand your treatment options

Early assessment can help identify risks and create a realistic plan.

What a Doctor May Assess

A doctor-led approach may include:

  • Medical consultation

  • Weight history review

  • BMI assessment

  • Waist circumference measurement

  • Blood pressure check

  • Blood tests if needed

  • HbA1c and glucose review

  • Cholesterol testing

  • Review of medications

  • Cardiovascular risk assessment

  • Treatment options

  • Follow-up guidance

This allows treatment decisions to be based on health needs rather than weight alone.

Benefits and Key Points to Understand

Protecting heart health through weight management is not about achieving a perfect body size.

Important points include:

  • Obesity can affect cardiovascular health

  • Waist circumference and metabolic markers matter

  • Weight management can improve several health factors

  • Lifestyle changes remain important

  • Medication may be suitable for some patients but not everyone

  • Regular medical assessment helps guide safer decisions

The goal is better health, improved quality of life, and reduced risk where possible.

Safety, Side Effects, and Important Considerations

Weight management medications may cause side effects and are not suitable for everyone.

In the SELECT trial, gastrointestinal side effects were more common among participants receiving semaglutide. Some participants discontinued treatment because of adverse events, particularly gastrointestinal problems. fileciteturn3file0

Possible side effects may include:

  • Nausea

  • Vomiting

  • Diarrhoea

  • Constipation

  • Digestive discomfort

Patients should discuss medical history, current medication, pregnancy status, and risk factors with a doctor before starting treatment.

Why Doctor-Led Care Matters

Weight management and cardiovascular health involve many factors.

A doctor can help assess:

  • Whether weight is affecting health

  • Which risk factors need attention

  • Whether medication is appropriate

  • How to monitor progress safely

  • How to manage side effects

The right approach is different for every patient.

Book a Weight Management Consultation in Bangkok

MedConsult Clinic provides doctor-led weight management consultations in Bangkok for patients who want to understand their health risks and available options.

A consultation may include discussion of weight history, metabolic health, cardiovascular risk factors, and appropriate testing.

Book a consultation at MedConsult Clinic to discuss a personalised weight management plan focused on long-term health.

Frequently Asked Questions

Can losing weight improve heart health?

 

Weight reduction may improve several cardiovascular risk factors, including blood pressure, blood sugar, cholesterol, and inflammation markers.

 

Yes. Obesity is associated with increased cardiovascular risk through effects on blood pressure, metabolism, inflammation, and body fat distribution.

No. Treatment depends on individual health risks, medical history, previous weight-loss attempts, and doctor assessment.

No. Healthy weight management also focuses on improving metabolic health, maintaining muscle, and creating sustainable lifestyle habits.

References

Lincoff AM, Brown-Frandsen K, Colhoun HM, et al.

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
New England Journal of Medicine. 2023;389:2221-2232.
https://doi.org/10.1056/NEJMoa2307563

Wilding JPH, Batterham RL, Calanna S, et al.

Once-Weekly Semaglutide in Adults with Overweight or Obesity.
New England Journal of Medicine. 2021;384:989-1002.

Sattar N, Lee MMY, Kristensen SL, et al.

Cardiovascular, Mortality, and Kidney Outcomes with GLP-1 Receptor Agonists in Patients with Type 2 Diabetes.
Lancet Diabetes & Endocrinology. 2021;9:653-662.